Charles Schwab
LHDX

Charles Schwab’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Charles Schwab’s Portfolio LHDX Stock Details LHDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-36,397
Closed -$242K – 3567
2021
Q2 		$242K Sell
36,397
-31,227
-46% -$197K ﹤0.01% 3261
2021
Q1 		$819K Buy
+67,624
New +$1.34M ﹤0.01% 2916

Other funds holding LHDX

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
PVI
Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
BOTOTLSJU
Board of Trustees of The Leland Stanford Junior University Redwood City, California $533M AUM 65.58% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return

Charles Schwab's LHDX Position: Q3 2021 in Review

Charles Schwab sold out of Lucira Health, Inc. Common Stock (LHDX) in Q3 2021, closing a stake of 36,397 shares — an estimated $242K sold.

Charles Schwab first reported a position in LHDX in Q1 2021 and held it in 2 quarters. The position peaked at $819K in Q1 2021. 36 funds tracked by Wall St. Rank hold LHDX as of Q3 2021.

  • Charles Schwab reported no remaining Lucira Health, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Charles Schwab sold 36,397 Lucira Health, Inc. Common Stock shares in Q3 2021, an estimated $242K.
  • Charles Schwab first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 2 quarters.
  • Charles Schwab's Lucira Health, Inc. Common Stock position peaked at $819K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q3 2021.

Based on Charles Schwab's 13F filing for Q3 2021, filed 16 Nov 2021.